Company / Assets per Share
Ligand Pharmaceuticals, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$81.68
FY2025
5-year range
$45.49 / $81.68
FY2021-FY2025
Trend
+52.3%
vs FY2024
Sector context
#12 of 210
Health Care
What the data says
Among 210 Health Care companies, Ligand Pharmaceuticals, Inc. is in the top 6% for assets per share. Assets per Share has increased for 3 consecutive years, from $45.49 in FY2022 to $81.68 in FY2025.
Based on SEC 10-K filings.
81.68 in FY2025 with a 5-year CAGR of +0.2%. Top quartile in the Health Care sector.
Improved from $46.44 to $81.68 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +21.5%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 210This company $81.68 Sector average $353.15
▼
-76.9% below sector average
Key checks
Key Insights
- Ligand Pharmaceuticals, Inc.'s assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 52.3% year-over-year.
- Ranks #12 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.68 | +52.3% |
| FY2024 | $53.64 | +15.5% |
| FY2023 | $46.44 | +2.1% |
| FY2022 | $45.49 | -43.6% |
| FY2021 | $80.70 | -0.3% |
| FY2020 | $80.98 | +12.5% |
| FY2019 | $71.99 | +20.8% |
| FY2018 | $59.62 | +85.8% |
| FY2017 | $32.09 | +6.4% |
| FY2016 | $30.16 | +17.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026